Isoform-specific activation of latent transforming growth factor β (LTGF-β) by reactive oxygen species

被引:228
作者
Jobling, Michael E.
Mott, Joni D.
Finnegan, Monica T.
Jurukovski, Vladimir
Erickson, Anna C.
Walian, Peter J.
Taylor, Scott E.
Ledbetter, Steven
Lawrence, Catherine M.
Rifkin, Daniel B.
Barcellos-Hoff, Mary Helen
机构
[1] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA
[2] Genzyme Corp, Cambridge, MA 02139 USA
[3] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA
[4] NYU, Sch Med, Dept Med, New York, NY 10016 USA
关键词
D O I
10.1667/RR0695.1
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The three mammalian transforming growth factor beta (TGF-beta) isoforms are each secreted in a latent complex in which TGF-beta homodimers are non-covalently associated with homodimers of their respective pro-peptide called the latency-associated peptide (LAP). Release of TGF-beta from its LAP, called activation, is required for binding of TGF-beta to cellular receptors, making extracellular activation a critical regulatory point for TGF-beta bioavailability. Our previous work demonstrated that latent TGF-beta 1 (LTGF-beta 1) is efficiently activated by ionizing radiation in vivo and by reactive oxygen species (ROS) generated by Fenton chemistry in vitro. In the current study, we determined the specific ROS and protein target that render LTGF-beta 1 redox sensitive. First, we compared LTGF-beta 1. LTGF-beta 2 and LTGF-beta 3 to determine the generality of this mechanism of activation and found that redox-mediated activation is restricted to the LTGF-beta 1 isoform. Next, e used scavengers to determine that ROS activation was a function of OH center dot availability, confirming oxidation as the primary mechanism. To identify which partner of the LTGF-beta 1 complex was functionally modified, each was exposed to ROS and tested for the ability to form a latent complex. Exposure of TGF-beta 1 did not alter its ability to associate with LAP, but exposing LAP-beta 1 to ROS prohibited this phenomenon, while treatment of ROS-exposed LAP-beta 1 with a mild reducing agent restored its ability to neutralize TGF-beta 1 activity. Taken together, these results suggest that ROS-induced oxidation in LAP-beta 1 triggers a conformational change that releases TGF-beta 1. Using site-specific mutation, we identified a methionine residue at amino acid position 253 unique to LAP-beta 1 as critical to ROS-mediated activation. We propose that LTGF-beta 1 contains a redox switch centered at methionine 253, which allows LTGF-beta 1 to act uniquely as an extracellular sensor of oxidative stress in tissues. (c) 2006 by Radiation Research Society.
引用
收藏
页码:839 / 848
页数:10
相关论文
共 50 条
[1]   Enhanced expression of neuropeptides in human breast cancer cell lines following irradiation [J].
Aalto, Y ;
Forsgren, S ;
Kjorell, U ;
Bergh, J ;
Franzen, L ;
Henriksson, R .
PEPTIDES, 1998, 19 (02) :231-239
[2]   AN ASSAY FOR TRANSFORMING GROWTH-FACTOR-BETA USING CELLS TRANSFECTED WITH A PLASMINOGEN-ACTIVATOR INHIBITOR-1 PROMOTER LUCIFERASE CONSTRUCT [J].
ABE, M ;
HARPEL, JG ;
METZ, CN ;
NUNES, I ;
LOSKUTOFF, DJ ;
RIFKIN, DB .
ANALYTICAL BIOCHEMISTRY, 1994, 216 (02) :276-284
[3]   Integrin αvβ6-mediated activation of latent TGF-β requires the latent TGF-β binding protein-1 [J].
Annes, JP ;
Chen, Y ;
Munger, JS ;
Rifkin, DB .
JOURNAL OF CELL BIOLOGY, 2004, 165 (05) :723-734
[4]   Making sense of latent TGFβ activation [J].
Annes, JP ;
Munger, JS ;
Rifkin, DB .
JOURNAL OF CELL SCIENCE, 2003, 116 (02) :217-224
[5]   NORMAL TISSUE-INJURY AFTER CANCER-THERAPY IS A LOCAL RESPONSE EXACERBATED BY AN ENDOCRINE EFFECT OF TGF-BETA [J].
ANSCHER, MS ;
KONG, FM ;
MURASE, T ;
JIRTLE, RL .
BRITISH JOURNAL OF RADIOLOGY, 1995, 68 (807) :331-333
[6]  
Barcellos-Hoff M. H., 1994, Molecular Biology of the Cell, V5, p139A
[7]   TRANSFORMING GROWTH-FACTOR-BETA ACTIVATION IN IRRADIATED MARINE MAMMARY-GLAND [J].
BARCELLOSHOFF, MH ;
DERYNCK, R ;
TSANG, MLS ;
WEATHERBEE, JA .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (02) :892-899
[8]  
BARCELLOSHOFF MH, 1993, CANCER RES, V53, P3880
[9]   Redox-mediated activation of latent transforming growth factor-beta 1 [J].
BarcellosHoff, MH ;
Dix, TA .
MOLECULAR ENDOCRINOLOGY, 1996, 10 (09) :1077-1083
[10]   Redox modulation of cellular signaling and metabolism through reversible oxidation of methionine sensors in calcium regulatory proteins [J].
Bigelow, DJ ;
Squier, TC .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2005, 1703 (02) :121-134